Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Apidra (Insulin Glulisine [rDNA Origin]) Injection
Company:  Aventis Pharmaceutical, Inc.
Application No.:  021629
Approval Date: 04/16/2004


Date created: June 282004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.